AAP
GMAB icon

Arax Advisory Partners’s Genmab GMAB Stock Holding History

Arax Advisory Partners’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70K Buy
2,549
+1,487
+140% +$39.5K ﹤0.01% 3000
2026
Q1 		$28.5K Sell
1,062
-1,883
-64% -$56.4K ﹤0.01% 1926
2025
Q4 		$90.7K Buy
2,945
+818
+38% +$25.5K ﹤0.01% 1375
2025
Q3 		$65.2K Buy
2,127
+2,120
+30,286% +$51.7K ﹤0.01% 1712
2025
Q2 		$3.47K Hold
7
– – ﹤0.01% 2369
2025
Q1 		$138 Buy
+7
New +$147 ﹤0.01% 2612

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arax Advisory Partners's GMAB Position: Q2 2026 in Review

Arax Advisory Partners increased its Genmab (GMAB) stake by 140% in Q2 2026, buying an estimated $39.5K and bringing the position to 2,549 shares worth $70K. The position accounts for ﹤0.01% of the portfolio, ranked #3000.

Arax Advisory Partners first reported a position in GMAB in Q1 2025 and has held it in 6 quarters since. The position peaked at $90.7K in Q4 2025. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Arax Advisory Partners held 2,549 shares of Genmab worth $70K as of Q2 2026.
  • Arax Advisory Partners bought 1,487 Genmab shares in Q2 2026, an estimated $39.5K.
  • Genmab made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3000 holding.
  • Arax Advisory Partners first reported a position in Genmab in Q1 2025 and has held it in 6 quarters since.
  • Arax Advisory Partners's Genmab position peaked at $90.7K in Q4 2025.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.